Latest News
Larimar Therapeutics, Inc.
- Larimar Therapeutics, Inc. Estimates – GETTEX:ZA71
- Form 4 Larimar Therapeutics Inc: John B. Harlow Jr (President and COO) For: 29 September
- Larimar Therapeutics (LRMR) Slips 0.25% to $1.99 as Shares Sit Between Key Levels - Andrews Pitchfork
- Larimar Therapeutics (LRMR) Ticks Higher to $2.02 as Shares Hold Above Key Support - Volume Profile
- John Harlow Joins Larimar Therapeutics as President and Chief Operating Officer
- Larimar Therapeutics (LRMR) Slips 3.91% to $3.07 as Small-Cap Biotech Tests Lower Support - Put Wall
- Larimar Therapeutics Names John Harlow President and Chief Operating Officer
- Larimar Therapeutics Names John Harlow COO
- Larimar Therapeutics names John Harlow president and COO By Investing.com
- Will Larimar Therapeutics (NASDAQ:LRMR) Spend Its Cash Wisely?
Headlines from the last 30 days, linking to the original publishers. See all market news →